Sai Life Sciences
SAILIFE · Pharma > Pharmaceuticals & Drugs Listing date: Dec. 18, 2024

Stock Price vs Company Growth
1d
0.9%
1w
0.9%
1m
5.9%
3m
17.3%
6m
28.5%
1y
55.3%
all
31.1%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 1,131 0.9%
928
1,185
Company Overview

Sales
2,192 Cr
Growth: 26.4%
Profit after Tax
349 Cr
Growth: 4.7%
Mid Cap
23,983 Cr
P/E: 69.2x
Industry P/E: 31.1x
Fundamentals

Sales (Cr) ₹ 2,192
Growth 26.4%
EBITDA 28.8%
P/S 10.9x
Dividend 0.0%
P/E 69.2x
Book Value ₹ 117
PEG Ratio 2.6x
ROE 15.0%
P/B 9.7x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

The company is a pure play fully-integrated, innovator-focused, contract research, development and manufacturing organization. It provides end-to-end services across the drug discovery, development and manufacturing value chain for small molecule new chemical entities to global pharmaceutical innovators companies and biotechnology firms.
Followers (1)